{"id":"https://openalex.org/W2736243769","doi":"https://doi.org/10.1212/wnl.80.7_supplement.p05.165","title":"Anti-VLA4-Mediated Inhibition of Humeral Autoimmunity in EAE: Dependence on Epithelial V-Like Antigen Expression (P05.165)","display_name":"Anti-VLA4-Mediated Inhibition of Humeral Autoimmunity in EAE: Dependence on Epithelial V-Like Antigen Expression (P05.165)","publication_year":2013,"publication_date":"2013-02-12","ids":{"openalex":"https://openalex.org/W2736243769","doi":"https://doi.org/10.1212/wnl.80.7_supplement.p05.165","mag":"2736243769"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.80.7_supplement.p05.165","doi":"https://doi.org/10.1212/wnl.80.7_supplement.p05.165","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1212/wnl.80.7_supplement.p05.165","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041109604","display_name":"Michael D. Carrithers","orcid":"https://orcid.org/0000-0001-5337-0804","observed_orcids":["https://orcid.org/0000-0001-5337-0804"]},"institutions":[{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Carrithers","raw_affiliation_strings":["University of Wisconsin Madison WI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Wisconsin Madison WI","institution_ids":["https://openalex.org/I135310074"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Erik Wright","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erik Wright","raw_affiliation_strings":["University of Wisconsin Madison"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Wisconsin Madison","institution_ids":["https://openalex.org/I135310074"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018317764","display_name":"Kusha Rahgozar","orcid":"https://orcid.org/0000-0002-6768-9768","observed_orcids":["https://orcid.org/0000-0002-6768-9768"]},"institutions":[{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kusha Rahgozar","raw_affiliation_strings":["University of Wisconsin Madison"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Wisconsin Madison","institution_ids":["https://openalex.org/I135310074"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066204730","display_name":"Nicholas E. Hallworth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas Hallworth","raw_affiliation_strings":["Biogen-Idec Cambridge"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biogen-Idec Cambridge","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088523974","display_name":"Stefan Lanker","orcid":"https://orcid.org/0000-0001-9625-9137","observed_orcids":["https://orcid.org/0000-0001-9625-9137"]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stefan Lanker","raw_affiliation_strings":["Biogen-Idec Portland OR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biogen-Idec Portland OR","institution_ids":["https://openalex.org/I1297540436"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.35131327,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"7_supplement","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.8906000256538391,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.8906000256538391,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.047200001776218414,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.009200000204145908,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vla-4","display_name":"VLA-4","score":0.8330000042915344},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.7820000052452087},{"id":"https://openalex.org/keywords/experimental-autoimmune-encephalomyelitis","display_name":"experimental autoimmune encephalomyelitis","score":0.9440000057220459},{"id":"https://openalex.org/keywords/humoral-autoimmunity","display_name":"humoral autoimmunity","score":0.953000009059906},{"id":"https://openalex.org/keywords/autoantigen-expression","display_name":"autoantigen expression","score":0.5019999742507935},{"id":"https://openalex.org/keywords/immunomodulation","display_name":"immunomodulation","score":0.5249999761581421}],"concepts":[{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.6817596554756165},{"id":"https://openalex.org/C2778957590","wikidata":"https://www.wikidata.org/wiki/Q798033","display_name":"CD19","level":3,"score":0.6556930541992188},{"id":"https://openalex.org/C2778486448","wikidata":"https://www.wikidata.org/wiki/Q494066","display_name":"Experimental autoimmune encephalomyelitis","level":3,"score":0.6407857537269592},{"id":"https://openalex.org/C163764329","wikidata":"https://www.wikidata.org/wiki/Q785022","display_name":"Autoantibody","level":3,"score":0.5529659390449524},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5181309580802917},{"id":"https://openalex.org/C2780130043","wikidata":"https://www.wikidata.org/wiki/Q192360","display_name":"Autoimmunity","level":3,"score":0.5132998824119568},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5119620561599731},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4875330626964569},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4795089066028595},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.4157392680644989}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.80.7_supplement.p05.165","doi":"https://doi.org/10.1212/wnl.80.7_supplement.p05.165","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1212/wnl.80.7_supplement.p05.165","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.6399999856948853}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2085361952","https://openalex.org/W2018456133","https://openalex.org/W1977106171","https://openalex.org/W2990463769","https://openalex.org/W2007469704","https://openalex.org/W2103205249","https://openalex.org/W2608149087","https://openalex.org/W4224270765","https://openalex.org/W2077944387","https://openalex.org/W2181579039"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Analyze":[1],"the":[2,15,22,50,90,138,214,231,237,272],"effects":[3],"of":[4,17,53,66,105,153,177,217,233,274,327,335],"epithelial":[5],"V-like":[6],"antigen":[7],"(EVA)":[8],"on":[9,56],"anti-VLA4":[10,54,134,142,190,207,244],"efficacy.":[11],"BACKGROUND:":[12],"Natalizumab":[13],"inhibits":[14],"transmigration":[16],"activated":[18,85],"T":[19,225],"lymphocytes":[20,76],"into":[21],"brain":[23],"and":[24,39,77,80,88,99,115,141,160,180,202,228,254],"is":[25,82,258,324],"highly":[26],"efficacious":[27],"in":[28,41,61,74,84,209,236,251,320],"multiple":[29],"sclerosis":[30],"(MS).":[31],"However,":[32],"from":[33,287],"a":[34],"pharmacogenomic":[35],"perspective,":[36],"its":[37],"efficacy":[38],"safety":[40],"specific":[42],"patients":[43],"remain":[44],"unclear.":[45],"DESIGN/METHODS:":[46],"Here":[47],"we":[48],"analyzed":[49],"therapeutic":[51,263],"effect":[52],"treatment":[55,208,245,275],"experimental":[57],"autoimmune":[58],"encephalomyelitis":[59],"(EAE)":[60],"mice":[62,95,110,145,168,187,212],"that":[63,243,255,267],"lack":[64],"expression":[65,257],"EVA.":[67],"This":[68,126],"molecule":[69],"has":[70,283,292,298,304],"been":[71],"previously":[72],"characterized":[73],"human":[75],"animal":[78],"models,":[79],"it":[81],"expressed":[83],"immune":[86],"cells":[87,179,235],"at":[89],"blood-cerebrospinal":[91],"fluid":[92],"barrier.":[93],"EVA-knockout":[94,203],"demonstrate":[96],"normal":[97],"development":[98],"lifespan.":[100],"RESULTS:":[101],"Following":[102],"active":[103],"induction":[104],"EAE":[106,114,128],"using":[107],"MOG35-55,":[108],"these":[109,144,268],"developed":[111],"more":[112],"severe":[113,127],"white":[116],"matter":[117],"tissue":[118],"injury":[119],"as":[120,196,312,332],"compared":[121,197],"to":[122,133,198,294,300],"wild":[123,185,199,210],"type":[124,167,186,200,211],"controls.":[125],"phenotype":[129],"did":[130],"not":[131],"respond":[132],"treatment.":[135],"In":[136,183],"both":[137],"control":[139,171],"antibody":[140,172],"conditions,":[143],"demonstrated":[146,174,191],"enhanced":[147],"serum":[148,181,193],"autoantibody":[149,194],"levels,":[150],"CNS":[151,175,219],"invasion":[152,176],"mature":[154],"B":[155,248],"lymphocyte":[156,226],"(CD19+,":[157],"CD21+,":[158],"sIgG+),":[159],"extensive":[161],"complement":[162],"deposition":[163],"within":[164],"lesions.":[165],"Wild":[166],"treated":[169,188],"with":[170,189,310],"also":[173,229],"CD19+CD21+sIgG+":[178,234],"autoantibody.":[182],"contrast,":[184],"reduced":[192,213,230],"levels":[195],"controls":[201],"mice.":[204],"As":[205],"expected,":[206],"total":[215],"numbers":[216],"all":[218],"mononuclear":[220],"cells,":[221],"markedly":[222],"decreased":[223],"CD4":[224],"invasion,":[227],"frequency":[232],"CNS.":[238],"CONCLUSIONS:":[239],"These":[240],"results":[241],"suggest":[242],"can":[246],"reduce":[247],"lymphocyte-mediated":[249],"autoimmunity":[250],"some":[252],"individuals":[253],"EVA":[256],"necessary":[259],"for":[260,308],"an":[261,313,325,333],"optimal":[262],"response.":[264],"We":[265],"postulate":[266],"findings":[269],"could":[270],"optimize":[271],"selection":[273],"responders.":[276],"Supported":[277],"by:":[278],"Biogen-Idec/Elan.":[279],"Disclosure:":[280],"Dr.":[281,290,296,302,315,322,330],"Carrithers":[282],"received":[284,305],"research":[285],"support":[286],"Biogen":[288,328],"Idec.":[289,329],"Wright":[291],"nothing":[293,299],"disclose.":[295,301],"Rahgozar":[297],"Hallworth":[303,316],"personal":[306],"compensation":[307],"activities":[309],"Biogen-Idec":[311],"employee.":[314],"holds":[317],"stock":[318,339],"options":[319],"Biogen-Idec.":[321],"Lanker":[323,331],"employee":[326,334],"Biogen-Idec,":[336],"may":[337],"hold":[338],"options.":[340]},"counts_by_year":[],"updated_date":"2026-10-26T11:51:55.731654","created_date":"2017-07-21T00:00:00"}